Darryl P. Leong

ORCID: 0000-0002-1968-169X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Imaging and Diagnostics
  • Cardiovascular Function and Risk Factors
  • Atrial Fibrillation Management and Outcomes
  • Cardiac pacing and defibrillation studies
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Cardiac Arrhythmias and Treatments
  • Advanced MRI Techniques and Applications
  • Cardiovascular Disease and Adiposity
  • Cardiac Valve Diseases and Treatments
  • Prostate Cancer Treatment and Research
  • Coronary Interventions and Diagnostics
  • Acute Myocardial Infarction Research
  • Cardiac electrophysiology and arrhythmias
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiac Structural Anomalies and Repair
  • Blood Pressure and Hypertension Studies
  • Cardiovascular Health and Risk Factors
  • Cancer, Lipids, and Metabolism
  • Cardiomyopathy and Myosin Studies
  • Frailty in Older Adults
  • Cardiac, Anesthesia and Surgical Outcomes
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac Health and Mental Health
  • Health disparities and outcomes
  • Heart Failure Treatment and Management

Population Health Research Institute
2016-2025

McMaster University
2016-2025

Hamilton Health Sciences
2016-2025

Impact
2018-2024

Flinders University
2009-2024

The University of Adelaide
2008-2024

East Kent Hospitals University NHS Foundation Trust
2024

Tolmar (United States)
2024

City of Hope
2024

Hamilton General Hospital
2014-2023

We evaluated whether rivaroxaban alone or in combination with aspirin would be more effective than for secondary cardiovascular prevention.In this double-blind trial, we randomly assigned 27,395 participants stable atherosclerotic vascular disease to receive (2.5 mg twice daily) plus (100 once daily), (5 daily). The primary outcome was a composite of death, stroke, myocardial infarction. study stopped superiority the rivaroxaban-plus-aspirin group after mean follow-up 23 months.The occurred...

10.1056/nejmoa1709118 article EN New England Journal of Medicine 2017-08-27
Sonia S. Anand Jackie Bosch John W. Eikelboom Stuart J. Connolly Rafael Díaz and 95 more Peter Widimsky Victor Aboyans Marco Alings Ajay K. Kakkar Katalin Keltai Aldo P. Maggioni Basil S. Lewis Stefan Störk Jun Zhu Patricio López‐Jaramillo Martin O’Donnell Patrick Commerford Dragoş Vinereanu Nana Pogosova Lars Rydén Keith A.A. Fox Deepak L. Bhatt Frank Misselwitz George Varigos Thomas Vanassche Álvaro Avezum Edmond Chen Kelley R. Branch Darryl P. Leong Shrikant I. Bangdiwala Robert G. Hart Salim Yusuf JORGELINA SALA Luis Cartasegna MARISA VICO Miguel Hominal Eduardo Hasbani ALBERTO CACCAVO Cesar Javier Zaidman DANIEL VOGEL Adrian D. Hrabar P. Schygiel Carlos Alberto Cuneo Hugo A Luquez Ignacio MacKinnon Rodolfo Andrés Ahuad Guerrero JUAN PABLO COSTABEL INES PALMIRA BARTOLACCI Oscar Montaña María Antonietta Barbieri Oscar Gómez Vilamajó RUBEN OMAR GARCIA DURAN LILIA BEATRIZ SCHIAVI Marcelo Garrido ADRIAN INGARAMO Anselmo Bordonava MARIA JOSE PELAGAGGE LEONARDO NOVARETTO JUAN PABLO ALBISU DI GENNERO LUZ MARIA IBANEZ SAGGIA MOIRA ALVAREZ Néstor A. Vita Stella M. Macı́n Ricardo D. Dran MARCELO CARDONA Luis Guzman RODOLFO JUAN SARJANOVICH Jesus Cuadrado SEBASTIAN NANI MARCOS RAUL LITVAK BRUNO Carolina Chacón Laura Maffei DIEGO GRINFELD NATALIA VENSENTINI CLAUDIO RODOLFO MAJUL Héctor Luciardi PATRICIA DEL CARMEN GONZALEZ COLASO FREDY ANTONI FERRE PACORA PAUL VAN DEN HEUVEL Peter Verhamme BAVO ECTOR PHILIPPE DEBONNAIRE Philippe van de Borne JEAN LEROY Herman Schroë Pascal Vranckx Ivan Elegeert E Hoffer KARL DUJARDIN CLARISSE INDIO DO BRASIL Dalton Bertolim Précoma JOSE ANTONIO ABRANTES Euler Roberto Fernandes Manenti Gilmar Reis José Francisco Kerr Saraiva Lília Nigro Maia Mauro Esteves Hernandes Paulo Roberto Ferreira ROSSI Fabio Rossi dos Santos Sérgio Luiz Zimmermann

10.1016/s0140-6736(17)32409-1 article EN The Lancet 2017-11-11

IMPORTANCEObesity is a risk factor for atrial fibrillation.Whether weight reduction and cardiometabolic management can reduce the burden of fibrillation not known.OBJECTIVE To determine effect factors on cardiac structure.DESIGN, SETTING, AND PATIENTS Single-center, partially blinded, randomized controlled study conducted between June 2010 December 2011 in Adelaide, Australia, among overweight obese ambulatory patients (N = 150) with symptomatic fibrillation.Patients underwent median 15...

10.1001/jama.2013.280521 article EN JAMA 2013-11-17
Flávia K. Borges Mohit Bhandari Ernesto Guerra-Farfán Ameen Patel Alben Sigamani and 95 more Masood Umer Maria Tiboni Maria del Mar Villar-Casares Vikas Tandon Jordi Tomás-Hernández Jordi Teixidor-Serra Victoria Avram Mitchell Winemaker Mmampapatla Thomas Ramokgopa Wojciech Szczeklik Giovanni Landoni Chew Yin Wang Dilshad Begum John Neary Anthony Adili Parag Sancheti Abdel‐Rahman Lawendy Mariano Balaguer-Castro Paweł Ślęczka Richard Jenkinson Aamer Nabi Nur Gavin Wood Robert J. Feibel Stephen J. McMahon Alen Sigamani Ekaterine Popova Bruce Biccard Iain Moppett Patrice Forget Paul Landais Michael McGillion Jessica Vincent Kumar Balasubramanian Valerie Harvey Yaiza Garcia-Sanchez Shirley Pettit Leslie Gauthier Gordon Guyatt David Conen Amit X. Garg Shrikant I. Bangdiwala Emilie P. Belley‐Côté Maura Marcucci André Lamy Richard P. Whitlock Yannick Le Manach Dean Fergusson Salim Yusuf P.J. Devereaux Laurent Veevaete Bernard le Polain de Waroux Patricia Lavand’homme Olivier Cornu Karim Tribak Jean Cyr Yombi Nassim Touil Maike Reul Jigme Tshering Bhutia Carol Clinckaert Dirk De Clippeleir Maike Reul Ameen Patel Vikas Tandon Leslie Gauthier Victoria Avram Mitchell Winemaker Justin de Beer Diane Simpson Andrew Worster Kim Alvarado Krysten Gregus Kelly H. Lawrence Darryl P. Leong Philip Joseph Patrick Magloire Benjamin Deheshi Stuart K. Bisland Thomas J. Wood Daniel Tushinski David Wilson Clive Kearon Yannick Le Manach Anthony Adili Maria Tiboni John Neary David D. Cowan Vickas Khanna Amna Zaki Janet C. Farrell Anne Marie MacDonald David Conen Steven CW. Wong Abdolreza Karbassi Douglas Steven Wright Harsha Shanthanna

10.1016/s0140-6736(20)30058-1 article EN The Lancet 2020-02-01

Abstract Background The measurement of handgrip strength (HGS) has prognostic value with respect to all‐cause mortality, cardiovascular mortality and disease, is an important part the evaluation frailty. Published reference ranges for HGS are mostly derived from Caucasian populations in high‐income countries. There a paucity information on normative values non‐Caucasian low‐ or middle‐income objective this study was develop healthy adults broad range ethnicities socioeconomically diverse...

10.1002/jcsm.12112 article EN cc-by-nc-nd Journal of Cachexia Sarcopenia and Muscle 2016-04-12

10.1016/s2213-8587(17)30283-8 article EN The Lancet Diabetes & Endocrinology 2017-08-29

Long-term continuous electrocardiographic monitoring shows a substantial prevalence of asymptomatic, subclinical atrial fibrillation (SCAF) in patients with pacemakers and cryptogenic stroke. Whether SCAF is also common other without these conditions unknown.We implanted subcutaneous monitors (St. Jude CONFIRM-AF) ≥65 years age attending cardiovascular or neurology outpatient clinics if they had no history but any the following: CHA2DS2-VASc score ≥2, sleep apnea, body mass index >30 kg/m2....

10.1161/circulationaha.117.028845 article EN Circulation 2017-08-05

BackgroundHypertension is considered the most important risk factor for cardiovascular diseases, but its control poor worldwide. We aimed to assess availability and affordability of blood pressure-lowering medicines, association with use these medicines pressure in countries at varying levels economic development.MethodsWe analysed availability, costs, data recorded from 626 communities 20 participating Prospective Urban Rural Epidemiological (PURE) study. Medicines were available if they...

10.1016/s2468-2667(17)30141-x article EN cc-by-nc-nd The Lancet Public Health 2017-09-01

The associations between the extent of forced expiratory volume in 1 s (FEV1) impairment and mortality, incident cardiovascular disease, respiratory hospitalisations are unclear, how these might vary across populations is unknown.In this international, community-based cohort study, we prospectively enrolled adults aged 35-70 years who had no intention moving residences for 4 from rural urban communities 17 countries. A portable spirometer was used to assess FEV1. FEV1 values were...

10.1016/s2214-109x(19)30070-1 article EN cc-by-nc-nd The Lancet Global Health 2019-04-15
Renato D. Lópes Celestia S. Higano Susan F. Slovin Adam J. Nelson Robert Bigelow and 95 more Per Settergren Sørensen Chiara Melloni Shaun G. Goodman Christopher P. Evans Jan Nilsson Deepak L. Bhatt Noel W. Clarke Tine Kold Olesen Belinda T. Doyle-Olsen Henriette Kristensen Lauren Arney Matthew T. Roe John H. Alexander Mirjam Mol-Arts Samreen Mansor-Lefebvre Konstantin Zubovskiy Allan Blemings Klaus A. Dugi Gerald S. Bloomfield Chris Kontos Adam D. DeVore J. Dedrick Jordan Brad J. Kolls J. B. Matthews Rajendra H. Mehta Thomas J. Povsic Michael Morse Kenneth W. Mahaffey Susan Halabi Darryl P. Leong Laurence Klotz Neil Fleshner G. Kenneth Jansz Jonathan Giddens R. Blair Egerdie Joseph L. Chin Joseph Zadra Richard Casey Jean Simard Tamim Niazi André‐Guy Martin Marek Babjuk Jaroslav Hájek Jiří Klečka Jiří Kubeš Jan Schraml Jitka Jakesova J Vaňásek Bohuslav Melichar Heikki Seikkula M. Abdiche Marc Colombel P. Debourdeau G. Robert Arnauld Villers Guillaume Ploussard Benjamin Pradère F. Bruyère Jean‐Luc Descotes I. Ouzaïd Alexander Winter Herbert Hanitzsch H. Sperling Ralf Eckert Peter Hammerer E. Stagge F. Seseke Silvio Szymula Aristotelis Bamias A. Thanos Konstantinos Hatzimouratidis Charalambos Mamoulakis Haralabos P. Kalofonos Elżbieta Oszukowska Katarzyna Madziarska Jacek Fijuth Mateusz Obarzanowski B. Yа. Alekseev Vagif Atduev Pushkar' DIu Evgeniy Veliev A. V. Zyryаnov С Б Петров Evgeny Kopyltsov Vadim Kozlov Ladislav Macko J. Dúbravický Richard Polak Obaidullah Mir Marek Vargovcak I. Minčík J. Kliment Frederico Gonçalves J Mikuláš Roman Sokol

The relative cardiovascular safety of gonadotropin-releasing hormone (GnRH) antagonists compared with GnRH agonists in men prostate cancer and known atherosclerotic disease remains controversial.In this international, multicenter, prospective, randomized, open-label trial, concomitant were randomly assigned 1:1 to receive the antagonist degarelix or agonist leuprolide for 12 months. primary outcome was time first adjudicated major adverse event (composite death, myocardial infarction,...

10.1161/circulationaha.121.056810 article EN Circulation 2021-08-30
Coming Soon ...